Recent advances in the analysis of adverse events at varying follow-up times in the benefit assessment of therapies: recommendations by the ATF / APF project group
| Autor: | Unkel, S, Ose, C, Knoerzer, D, Skipka, G, Langer, F, Schmoor, C, Proctor, T, Beyersmann, J, Gillhaus, J, Friede, T |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: | |
| Zdroj: | 62. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS); 20170917-20170921; Oldenburg; DOCAbstr. 048 /20170829/ |
| DOI: | 10.3205/17gmds074 |
| Popis: | The analysis of adverse events is a key component in the assessment of a drug’s safety profile which is also required within the context of the early benefit assessment in Germany. Inappropriate analysis methods may result in misleading conclusions on a therapy’s safety and consequently[for full text, please go to the a.m. URL] 62. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|